Tioga Pharmaceuticals' Series B - II Round

Tioga Pharmaceuticals raised a round of funding on April 15, 2012.

Tioga Pharmaceuticals, formerly Icon Pharmaceuticals, is focused on the development of therapies for the treatment of gastrointestinal diseases. Tioga is developing asimadoline in Phase 3 clinical tri…

Articles about Tioga Pharmaceuticals' Series B - II Round: